{"abstract": "The Food and Drug Administration said concerns over bleeding outweighed the evidence that Xarelto reduced the risk of blood clots.", "web_url": "https://www.nytimes.com/2012/05/24/business/fda-panel-votes-against-expansion-of-xarelto.html", "snippet": "The Food and Drug Administration said concerns over bleeding outweighed the evidence that Xarelto reduced the risk of blood clots.", "lead_paragraph": "A federal advisory panel narrowly recommended against expanding the use of the Johnson & Johnson drug Xarelto on Wednesday, saying concerns over dangerous bleeding outweighed evidence that the drug helped reduce the risk of blood clots in patients with serious heart problems.", "print_section": "B", "print_page": "3", "source": "The New York Times", "multimedia": [], "headline": {"main": "F.D.A. Panel Votes Against Expanding Use of an Anticoagulant", "kicker": null, "content_kicker": null, "print_headline": "F.D.A. Panel Votes Against Expanding Use of an Anticoagulant", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "organizations", "value": "Janssen Pharmaceutica", "rank": 1, "major": "N"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 2, "major": "N"}, {"name": "subject", "value": "Blood Clots", "rank": 3, "major": "N"}, {"name": "organizations", "value": "Food and Drug Administration", "rank": 4, "major": "N"}, {"name": "organizations", "value": "Johnson & Johnson", "rank": 5, "major": "N"}], "pub_date": "2012-05-24T00:01:58+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Katie Thomas", "person": [{"firstname": "Katie", "middlename": null, "lastname": "Thomas", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/93deb2c1-de00-5fb6-a1a6-f3f7638b6fc5", "word_count": 405, "uri": "nyt://article/93deb2c1-de00-5fb6-a1a6-f3f7638b6fc5"}